These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 5295647)

  • 1. Treatment of occlusive diseases of the arteries in the limbs with pyridinol-carbamate.
    Matsumoto K; Sato K; Tanaka S
    Jpn Heart J; 1966 Jan; 7(1):87-93. PubMed ID: 5295647
    [No Abstract]   [Full Text] [Related]  

  • 2. Pyridinolcarbamate, bradykinin antagonist, in patients suffering from arteriosclerosis obliterans and thromboangiitis obliterans (Buerger's disease); a preliminary report on the treatment of human atherosclerosis.
    Shimamoto T; Atsumi T
    Jpn Heart J; 1965 Sep; 6(5):407-15. PubMed ID: 5294603
    [No Abstract]   [Full Text] [Related]  

  • 3. [Anginin (pyridinol carbamate) therapy of coronary atherosclerosis and obliterating atherosclerosis of the arteries of the lower extremities].
    Liusov VA; Belousov IuB; Martynov AI; Koroleva SA; Zimin VS
    Kardiologiia; 1972 Nov; 12(11):39-45. PubMed ID: 4655879
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical tests using pyridinol carbamate on the arterial circulation and blood coagulation in patients with arteriosclerosis obliterans].
    De Soldati L; Castro CM; Grilli H; Reussi J
    Prensa Med Argent; 1969 May; 56(12):546-53. PubMed ID: 5343928
    [No Abstract]   [Full Text] [Related]  

  • 5. [New data on the use of halidor in obliterative diseases of arteries of the extremities].
    Zolotarevskiĭ VIa; Taranovich VA; Maksimova TV
    Klin Med (Mosk); 1969 Feb; 47(2):67-71. PubMed ID: 5379263
    [No Abstract]   [Full Text] [Related]  

  • 6. [Intra-arterial infusion therapy of patients with the ischemic syndrome in thrombo-obliterating diseases of the lower extremities in ambulatory conditions].
    Savel'ev IuS
    Vestn Khir Im I I Grek; 1990 Sep; 145(9):131-4. PubMed ID: 1962927
    [No Abstract]   [Full Text] [Related]  

  • 7. A clinical trial with pyridinolcarbamate in the treatment of patients with obstructive diseases of the peripheral arteries.
    Zelikovsky A; Urca I; Shaklai M; de Vries A
    Jpn Heart J; 1973 Jan; 14(1):12-21. PubMed ID: 4541560
    [No Abstract]   [Full Text] [Related]  

  • 8. [Problems of geriatric surgery of arterial occlusive disorders].
    Loose KE
    Dtsch Med Wochenschr; 1966 Apr; 91(17):812-4. PubMed ID: 5909663
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of prostaglandin E1 in chronic obliterative diseases of peripheral arteries].
    Zhang GS
    Zhonghua Wai Ke Za Zhi; 1988 Sep; 26(9):541-2, 573. PubMed ID: 3243146
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of pyridinol carbamate (Anginin) in peripheral arterial blood circulation disorders].
    Heisig N; Westermann KW; Stolterfoht CA; Zaki J
    Med Klin; 1970 Dec; 65(52):2289-93. PubMed ID: 5522670
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of 1-4-dihydrazinophthalazine on arterial circulation of the limbs in normal and artery disease patients].
    Leoni E
    Gazz Int Med Chir; 1965 Sep; 69(17):1468-74. PubMed ID: 5837540
    [No Abstract]   [Full Text] [Related]  

  • 12. Arteriography of the extremities, with an analysis of the occlusive diseases of the arteries in the lower extremities.
    Suzuki S
    Am J Roentgenol Radium Ther Nucl Med; 1969 Jun; 106(2):400-17. PubMed ID: 5789504
    [No Abstract]   [Full Text] [Related]  

  • 13. [Late results of treatment of circulatory disorders of the lower extremities with Mydocalm].
    Chmielewski F
    Wiad Lek; 1969 Mar; 22(6):575-80. PubMed ID: 5788875
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of phenformin and stanozol administration on lipid metabolism in patients with occlusive vascular diseases].
    Perzanowski A; Bielawiec M; Myśliwiec M
    Pol Tyg Lek; 1972 Jan; 27(5):174-6. PubMed ID: 5010762
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of organic diseases of peripheral arteries with nicotinic acid derivatives].
    Liszewska D; Lukasik E
    Pol Tyg Lek; 1967 May; 22(21):794-6. PubMed ID: 6041002
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of pyrimidinol-carbamate in the therapy of peripheral obliterative arteriopathies].
    Tardito E; Trezzi M; Papackaralambus D
    Minerva Cardioangiol; 1970 Dec; 18(12):692-705. PubMed ID: 5532336
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the treatment of "intermittent claudication" in chronic peripheral obliterating arteriopathies of the lower extremities caused by arteriosclerosis and Buerger's disease].
    Seghezzi R; Pedroni G; Borri P
    Chir Ital; 1967; 19():Suppl 2:222+. PubMed ID: 5190600
    [No Abstract]   [Full Text] [Related]  

  • 18. [Taurine in the therapy of obliterating arteriopathy of the lower extremities. I. Clinical results in various evolutive phases].
    Zanelli G; Ferrero S; Patrone P
    Minerva Cardioangiol; 1971 Nov; 19(11):605-15. PubMed ID: 5128422
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapeutic acquisitions on chronic obliterating peripheral arterial diseases of the lower limbs].
    Guagliano G; Bagliani A; Borri P
    Minerva Med; 1976 May; 67(25):1648-55. PubMed ID: 778666
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prostacyclin in treatment of peripheral vascular disease of lower extremities (author's transl)].
    Szczeklik A; Głusko P; Gryglewski R; Szczeklik J; Kostka-Trabka E; Grodzińska L; Nizanowski R; Dembińska-Kieć A; Skawiński S; Bieroń K; Billewicz O; Telesz E
    Przegl Lek; 1980; 37(9):659-62. PubMed ID: 6106960
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.